Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Voyager Therapeutics (VYGR) Interest & Investment Income: 2014-2024

Historic Interest & Investment Income for Voyager Therapeutics (VYGR) over the last 11 years, with Dec 2024 value amounting to $18.3 million.

  • Voyager Therapeutics' Interest & Investment Income fell 47.91% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.5 million, marking a year-over-year decrease of 28.52%. This contributed to the annual value of $18.3 million for FY2024, which is 56.37% up from last year.
  • According to the latest figures from FY2024, Voyager Therapeutics' Interest & Investment Income is $18.3 million, which was up 56.37% from $11.7 million recorded in FY2023.
  • In the past 5 years, Voyager Therapeutics' Interest & Investment Income registered a high of $18.3 million during FY2024, and its lowest value of -$390,000 during FY2021.
  • For the 3-year period, Voyager Therapeutics' Interest & Investment Income averaged around $10.6 million, with its median value being $11.7 million (2023).
  • As far as peak fluctuations go, Voyager Therapeutics' Interest & Investment Income tumbled by 123.51% in 2021, and later spiked by 559.49% in 2022.
  • Over the past 5 years, Voyager Therapeutics' Interest & Investment Income (Yearly) stood at $1.7 million in 2020, then crashed by 123.51% to -$390,000 in 2021, then soared by 559.49% to $1.8 million in 2022, then skyrocketed by 554.07% to $11.7 million in 2023, then surged by 56.37% to $18.3 million in 2024.